These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 7592779)
1. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. Grugel S; Finkenzeller G; Weindel K; Barleon B; Marmé D J Biol Chem; 1995 Oct; 270(43):25915-9. PubMed ID: 7592779 [TBL] [Abstract][Full Text] [Related]
2. Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells. Okajima E; Thorgeirsson UP Biochem Biophys Res Commun; 2000 Apr; 270(1):108-11. PubMed ID: 10733912 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
4. Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis. Feleszko W; Bałkowiec EZ; Sieberth E; Marczak M; Dabrowska A; Giermasz A; Czajka A; Jakóbisiak M Int J Cancer; 1999 May; 81(4):560-7. PubMed ID: 10225445 [TBL] [Abstract][Full Text] [Related]
5. Angiogenesis induced by urothelial cells (HCV-29) and their v-ras and v-raf transfectants. Przybyszewska M; Miłoszewska J; Janik P Cancer Lett; 1998 Sep; 131(2):157-61. PubMed ID: 9851248 [TBL] [Abstract][Full Text] [Related]
6. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Finkenzeller G; Sparacio A; Technau A; Marmé D; Siemeister G Oncogene; 1997 Aug; 15(6):669-76. PubMed ID: 9264407 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Mazure NM; Chen EY; Yeh P; Laderoute KR; Giaccia AJ Cancer Res; 1996 Aug; 56(15):3436-40. PubMed ID: 8758908 [TBL] [Abstract][Full Text] [Related]
8. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum. Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742 [TBL] [Abstract][Full Text] [Related]
11. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Rak J; Mitsuhashi Y; Sheehan C; Tamir A; Viloria-Petit A; Filmus J; Mansour SJ; Ahn NG; Kerbel RS Cancer Res; 2000 Jan; 60(2):490-8. PubMed ID: 10667605 [TBL] [Abstract][Full Text] [Related]
12. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. Milanini J; Viñals F; Pouysségur J; Pagès G J Biol Chem; 1998 Jul; 273(29):18165-72. PubMed ID: 9660776 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of theobromine on induction of angiogenesis and VEGF mRNA expression in v-raf transfectants of human urothelial cells HCV-29. Skopinska-Rózewska E; Janik P; Przybyszewska M; Sommer E; Bialas-Chromiec B Int J Mol Med; 1998 Dec; 2(6):649-52. PubMed ID: 9850731 [TBL] [Abstract][Full Text] [Related]
14. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. Soker S; Fidder H; Neufeld G; Klagsbrun M J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443 [TBL] [Abstract][Full Text] [Related]